PAA 7.69% 21.0¢ pharmaust limited

Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing, page-125

  1. 11,816 Posts.
    lightbulb Created with Sketch. 5987

    Here is the keystone for previous announcements -Pre MT , which was described recently as the Dark Ageshttps://hotcopper.com.au/data/attachments/5744/5744225-346f7739bbebd433a14be326d705eb37.jpg

    Last years AGM ASX Announcement was clear , K9 Commercial Outcome 2023

    July 4c
    Corporate outcome targeted CY23 on the licensing or sale of MPL’s vet cancer
    applications following commercially valuable Phase 2 outcomes

    July K9 Update
    The negotiations to date are consistent with the Company’s strategy of the licensing or
    sale of MPL’s vet cancer applications following commercially valuable Phase 2 outcomes.

    and the announcement that was Licensing or outright sale of the K9 Oncology Treatment .... to late on a Friday to look up the date

    Big Week coming , AGM plus CEO MT and PI Mathers to present plus PAA are Silver Sponsors of the Event so that should deliver some great opportunities to "spread the word"

    Hope everyone has a relaxing weekend with friends and family ,,NZT

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.